Deutsche Bank AG Purchases 156,524 Shares of Teleflex Incorporated (NYSE:TFX)

Deutsche Bank AG increased its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 62.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 407,129 shares of the medical technology company's stock after acquiring an additional 156,524 shares during the period. Deutsche Bank AG owned about 0.88% of Teleflex worth $72,461,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in TFX. Barclays PLC lifted its position in shares of Teleflex by 1.6% in the third quarter. Barclays PLC now owns 89,907 shares of the medical technology company's stock worth $22,233,000 after purchasing an additional 1,426 shares in the last quarter. Franklin Resources Inc. increased its stake in Teleflex by 64.3% in the 3rd quarter. Franklin Resources Inc. now owns 9,683 shares of the medical technology company's stock valued at $2,298,000 after buying an additional 3,790 shares during the last quarter. Principal Financial Group Inc. lifted its position in Teleflex by 2.7% during the 3rd quarter. Principal Financial Group Inc. now owns 80,409 shares of the medical technology company's stock worth $19,887,000 after buying an additional 2,086 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Teleflex by 4.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,305 shares of the medical technology company's stock worth $588,000 after buying an additional 128 shares during the last quarter. Finally, Czech National Bank grew its holdings in shares of Teleflex by 4.9% in the 4th quarter. Czech National Bank now owns 10,070 shares of the medical technology company's stock valued at $1,792,000 after acquiring an additional 472 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

TFX has been the subject of a number of analyst reports. Raymond James downgraded Teleflex from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a report on Wednesday, March 12th. Morgan Stanley dropped their price target on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research report on Monday, May 5th. StockNews.com downgraded shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Finally, Wells Fargo & Company lowered their price objective on shares of Teleflex from $146.00 to $137.00 and set an "equal weight" rating on the stock in a research note on Friday, May 2nd. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, Teleflex presently has an average rating of "Hold" and an average target price of $164.63.

Teleflex Stock Performance

Shares of TFX traded up $2.66 during midday trading on Friday, reaching $129.15. 542,769 shares of the stock were exchanged, compared to its average volume of 640,107. The stock's 50 day simple moving average is $133.03 and its 200 day simple moving average is $163.88. The company has a market cap of $5.71 billion, a P/E ratio of 25.67, a PEG ratio of 1.73 and a beta of 1.17. Teleflex Incorporated has a twelve month low of $120.06 and a twelve month high of $249.91. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.88 by $0.03. The business had revenue of $700.67 million during the quarter, compared to analysts' expectations of $699.37 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business's revenue was down 5.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $3.21 EPS. On average, sell-side analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th will be paid a dividend of $0.34 per share. The ex-dividend date is Tuesday, May 20th. This represents a $1.36 dividend on an annualized basis and a yield of 1.05%. Teleflex's dividend payout ratio (DPR) is presently 42.90%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.